Solid Biosciences Inc. (SLDB) stock

SLDBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30

$6.84−0.16 (-2.29%)

Close on Nov 13, 2026Market cap $733.42MP/E –Yield –

Solid Biosciences operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2022 it was -1315.2%, against -530.5% the year before.

Period	Period end	Value	Change (pts)
FY2022	Dec 31, 2022	-1315.2%	−784.7
FY2021	Dec 31, 2021	-530.5%	–

See a number that looks wrong?